Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...

Cipla share price will remain in focus after the United States Food and Drug Administration (USFDA) has classified the ...

Mumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro ...

Samvardhana Motherson, Garden Reach Shipbuilders, NLC India and Central Bank of India are also among the stocks to watch in ...

The USFDA has conducted routine cGMP inspection at the facility in the period between November 7 through November 13, 2024.

CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical ...

Cipla: The pharmaceutical company said that it will invest approximately ZAR 900 million (nearly Rs 417.93 crore) in equity share capital of wholly owned subsidiary Cipla Medpro South Africa ...

Stocks including LIC, Bharat Electronics, Vedanta, Glenmark Pharma, Cipla, FirstCry, NHPC, VA Tech Wabag and more will be in ...

Cipla, one of the leading pharmaceutical companies ... while margins improved by 184 basis points to 28.1% in Q3FY25. The company said its deep market focus strategy in Emerging Markets and ...

Q3 Earnings, Results 2025: Companies like TVS Motor, Hindustan Zinc, Hyundai Motor, GMR Airports, Bajaj Auto, Cipla, Piramal Pharma ... Ltd., the parent company of travel aggregator Ixigo ...

Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by ...